Ledger.Open graph →
SEC Form D · filed January 27, 2017

Swift Biosciences, Inc

Offering
$3.5M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Jack Ball, Jr · Ann Arbor, MIDirectorEric Halverson · Ann Arbor, MIExecPeter Kleinhenz · Ann Arbor, MIDirectorVladimir Makarov · Ann Arbor, MIExec · DirectorDan Watkins · Ann Arbor, MIDirectorWalter Young · Ann Arbor, MIDirectorTimothy Harkins, Phd · Ann Arbor, MIExec · DirectorAlan W. Djanogly · London, United KingdomDirectorNezu Asia Capital Management Limited · Hong Kong, Hong KongExecValara Capital Management, LLC · Armonk, NYExec · DirectorJustin W. Slatky · New York, NYDirectorNicholas Longcroft · Central Hong Kong, Hong KongExec · DirectorWilliam D. Cohen · Armonk, NYDirectorRobert D. Simmons · Armonk, NYDirectorGeorge Evans · Whitehouse Station, NJDirectorJohn Phinney · Wilton, CTDirectorRashid Bashir · Champaign, ILExec · DirectorBobby Reddy · Champaign, ILDirectorBruce V. Michelson · St. Louis, MOExecJack L. Porter · St. Louis, MOExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗